Close

Ratings by Leerink Partners (Andrew Berens)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2024 Immunome Inc. IMNM New Coverage Outperform
(N/A)
17.48
(23.61)
35.07% Details
11/7/2023 Zentalis Pharmaceuticals ZNTL Downgrade Market Perform
(Outperform)
12.48
(13.64)
9.29% Details
11/7/2023 Mirati Therapeutics MRTX Downgrade Market Perform
(Outperform)
56.27
(58.70)
4.32% Details
6/26/2023 BeiGene, Ltd. BGNE Maintain Outperform
(N/A)
 
 
  Details
6/5/2023 Blueprint Medicines BPMC Downgrade Underperform
(Market Perform)
58.22
(89.49)
53.71% Details
5/30/2023 Elevation Oncology ELEV Upgrade Outperform
(Market Perform)
5.02
(2.56)
-49% Details
3/27/2023 Regeneron Pharma REGN Upgrade Outperform
(Market Perform)
820.00
(981.20)
19.66% Details
2/10/2023 Abbvie ABBV Upgrade Market Perform
(Underperform)
148.70
(178.09)
19.76% Details
12/21/2022 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
11/7/2022 Elevation Oncology ELEV Downgrade Market Perform
(Outperform)
0.95
(2.56)
169.47% Details
11/2/2022 Eli Lilly LLY Maintain Outperform
(N/A)
 
 
  Details
10/21/2022 Zymeworks ZYME Downgrade Market Perform
(Outperform)
6.45
(11.94)
85.12% Details
10/13/2022 BeiGene, Ltd. BGNE Upgrade Outperform
(Market Perform)
125.51
(155.10)
23.58% Details
10/12/2022 Merus N.V. MRUS Maintain Outperform
(N/A)
 
 
  Details
9/12/2022 Deciphera DCPH Maintain Outperform
(N/A)
 
 
  Details
8/3/2022 Blueprint Medicines BPMC Maintain Market Perform
(N/A)
 
 
  Details
7/27/2022 Agios Pharma AGIO Upgrade Outperform
(Market Perform)
19.51
(32.99)
69.09% Details
7/25/2022 Regeneron Pharma REGN Downgrade Market Perform
(Outperform)
586.11
(981.20)
67.41% Details
6/10/2022 Cogent COGT Maintain Outperform
(N/A)
 
 
  Details
5/23/2022 Regeneron Pharma REGN New Coverage Outperform
(N/A)
657.15
(981.20)
49.31% Details
5/23/2022 Radius Health RDUS New Coverage Market Perform
(N/A)
5.84
(23.97)
310.45% Details
5/23/2022 Pfizer PFE New Coverage Market Perform
(N/A)
50.65
(27.76)
-45.19% Details
5/23/2022 Gilead Sciences GILD New Coverage Market Perform
(N/A)
63.27
(73.55)
16.25% Details
5/23/2022 Eli Lilly LLY New Coverage Outperform
(N/A)
286.27
(769.54)
168.82% Details
5/23/2022 Amgen AMGN New Coverage Market Perform
(N/A)
244.77
(289.18)
18.14% Details
5/23/2022 Abbvie ABBV New Coverage Underperform
(N/A)
151.72
(178.09)
17.38% Details
5/13/2022 Cullinan Management CGEM Maintain Outperform
(N/A)
 
 
  Details
5/4/2022 AstraZeneca AZN Maintain Outperform
(N/A)
 
 
  Details
4/11/2022 Zentalis Pharmaceuticals ZNTL Maintain Outperform
(N/A)
 
 
  Details
3/17/2022 BeiGene, Ltd. BGNE Downgrade Market Perform
(Outperform)
183.33
(125.51)
-31.54% Details
2/23/2022 Agios Pharma AGIO Maintain Market Perform
(N/A)
 
 
  Details
2/17/2022 Blueprint Medicines BPMC Downgrade Market Perform
(Outperform)
74.90
(89.49)
19.48% Details
12/20/2021 Compass Therapeutics CMPX New Coverage Outperform
(N/A)
3.06
(1.79)
-41.5% Details
12/10/2021 Zymeworks ZYME Upgrade Outperform
(Market Perform)
16.12
(11.94)
-25.93% Details
11/24/2021 Aura Biosciences AURA New Coverage Outperform
(N/A)
19.82
(8.89)
-55.15% Details
11/18/2021 Agios Pharma AGIO Maintain Market Perform
(N/A)
 
 
  Details
11/12/2021 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
11/10/2021 HOOKIPA Pharma Inc. HOOK Maintain Outperform
(N/A)
 
 
  Details
11/1/2021 Theseus Pharmaceuticals Inc. THRX New Coverage Outperform
(N/A)
17.12
(4.06)
-76.29% Details
10/28/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/21/2021 Mirati Therapeutics MRTX Maintain Outperform
(N/A)
 
 
  Details
9/20/2021 Tango Therapeutics Inc. TNGX New Coverage Outperform
(N/A)
17.30
(11.50)
-33.53% Details
7/29/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
7/20/2021 Elevation Oncology ELEV New Coverage Outperform
(N/A)
12.10
(2.56)
-78.84% Details
6/17/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
6/14/2021 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
6/11/2021 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 Epizyme EPZM Upgrade Outperform
(Underperform)
6.81
(1.47)
-78.41% Details
4/14/2021 Global Blood Therapeutics GBT New Coverage Outperform
(N/A)
40.18
(68.49)
70.46% Details
3/16/2021 Merus N.V. MRUS New Coverage Outperform
(N/A)
22.04
(47.45)
115.29% Details
3/11/2021 AVEO Pharmaceuticals AVEO Maintain Outperform
(N/A)
 
 
  Details
3/1/2021 Agios Pharma AGIO Downgrade Market Perform
(Outperform)
47.44
(32.99)
-30.46% Details
2/26/2021 Agios Pharma AGIO Downgrade Market Perform
(Outperform)
50.29
(47.44)
-5.67% Details
2/25/2021 Zymeworks ZYME Downgrade Market Perform
(Outperform)
40.30
(11.94)
-70.37% Details
2/10/2021 Deciphera DCPH Upgrade Outperform
(Market Perform)
48.32
(16.06)
-66.76% Details
2/2/2021 Cullinan Management CGEM New Coverage Outperform
(N/A)
33.77
(18.00)
-46.7% Details
12/28/2020 Kinnate Biopharma KNTE New Coverage Outperform
(N/A)
38.00
(2.51)
-93.39% Details
12/22/2020 Agios Pharma AGIO Maintain Outperform
(N/A)
 
 
  Details
12/17/2020 Cogent COGT New Coverage Outperform
(N/A)
10.53
(7.44)
-29.34% Details
12/8/2020 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
12/7/2020 HOOKIPA Pharma Inc. HOOK Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Epizyme EPZM Maintain Market Perform
(N/A)
 
 
  Details
9/22/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/14/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
8/13/2020 AVEO Pharmaceuticals AVEO New Coverage Outperform
(N/A)
4.40
(15.00)
240.91% Details
8/7/2020 Puma Biotechnology PBYI Maintain Market Perform
(N/A)
 
 
  Details
7/28/2020 Zentalis Pharmaceuticals ZNTL Maintain Outperform
(N/A)
 
 
  Details
7/14/2020 Forma Therapeutics FMTX New Coverage Outperform
(N/A)
38.53
(20.01)
-48.07% Details
6/1/2020 AstraZeneca AZN Maintain Outperform
(N/A)
 
 
  Details
4/29/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
4/29/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
4/28/2020 Zentalis Pharmaceuticals ZNTL New Coverage Outperform
(N/A)
31.76
(13.64)
-57.05% Details
4/27/2020 Clovis Oncology CLVS Downgrade Underperform
(Market Perform)
9.03
(0.08)
-99.11% Details
3/10/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
3/4/2020 BeiGene, Ltd. BGNE Maintain Outperform
(N/A)
 
 
  Details
2/7/2020 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
1/27/2020 AstraZeneca AZN Maintain Outperform
(N/A)
 
 
  Details
1/24/2020 Epizyme EPZM Downgrade Market Perform
(Outperform)
26.72
(1.47)
-94.5% Details
1/16/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
10/29/2019 Deciphera DCPH Upgrade Market Perform
(Underperform)
39.07
(16.06)
-58.89% Details
9/30/2019 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
9/24/2019 Clovis Oncology CLVS Downgrade Market Perform
(Outperform)
4.59
(0.08)
-98.26% Details
7/31/2019 Incyte INCY Maintain Market Perform
(N/A)
 
 
  Details
7/31/2019 Mirati Therapeutics MRTX Maintain Outperform
(N/A)
 
 
  Details
5/13/2019 HOOKIPA Pharma Inc. HOOK New Coverage Outperform
(N/A)
13.84
(0.64)
-95.38% Details
2/15/2019 Agios Pharma AGIO Upgrade Outperform
(Market Perform)
54.03
(32.99)
-38.94% Details
1/8/2019 Loxo Oncology LOXO Downgrade Market Perform
(Outperform)
139.87
(234.80)
67.87% Details
1/7/2019 Epizyme EPZM Upgrade Outperform
(Market Perform)
5.98
(26.72)
346.82% Details
12/4/2018 Clovis Oncology CLVS Upgrade Outperform
(Market Perform)
19.08
(4.59)
-75.94% Details
12/4/2018 Tesaro TSRO Downgrade Market Perform
(Outperform)
46.38
(74.96)
61.62% Details
10/1/2018 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
9/25/2018 Incyte INCY New Coverage Market Perform
(N/A)
66.59
(60.59)
-9.01% Details
9/25/2018 Clovis Oncology CLVS New Coverage Market Perform
(N/A)
32.38
(19.08)
-41.07% Details
9/25/2018 Agios Pharma AGIO New Coverage Market Perform
(N/A)
73.56
(54.03)
-26.55% Details
9/25/2018 Tesaro TSRO New Coverage Outperform
(N/A)
37.69
(46.38)
23.06% Details
9/25/2018 Seattle Genetics SGEN New Coverage Outperform
(N/A)
77.76
(228.74)
194.16% Details
9/25/2018 Loxo Oncology LOXO New Coverage Outperform
(N/A)
159.27
(139.87)
-12.18% Details
9/25/2018 Deciphera DCPH New Coverage Underperform
(N/A)
38.97
(39.07)
0.26% Details
9/25/2018 Blueprint Medicines BPMC New Coverage Outperform
(N/A)
69.61
(89.49)
28.56% Details
9/25/2018 BeiGene, Ltd. BGNE New Coverage Outperform
(N/A)
163.97
(155.10)
-5.41% Details